Description
Dupilumab, marketed under the brand name DUPIXENT, It is an prescription medication that has been approved Dupixent (dupilumab) on March 28, 2017 for the treatment of moderate-to-severe atopic dermatitis in adults.
What is DUPIXENT (dupilumab) ?
Dupilumab is indicated for the treatment of moderate-to-severe atopic dermatitis, moderate-to-severe asthma, and for the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP). It has been shown to be effective at treating aspirin-exacerbated respiratory disease (AERD), a typically difficult to treat condition where aspirin intolerant patients have both CRSwNP and asthma.
In May 2022, the indication for dupilumab was updated to include the treatment of eosinophilic esophagitis in people aged twelve years of age and older weighing at least 40 kilograms (88 lb).
In September 2022, the indication for dupilumab was updated to include the treatment of adults with prurigo nodularis (PN).
In March 2023, the EMA approved dupilumab for the treatment of severe atopic dermatitis in children aged six months to five years who are candidates for systemic therapy.
How to order approved “DUPIXENT (dupilumab) for injection” Medicine?
DUPIXENT (Dupilumab) Injection is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing DUPIXENT and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.
We can ship to :
Verve Biosciences offers assistance in importing the anti-cancer medication DUPIXENT (dupilumab) for injection. To inquire about the total cost of DUPIXENT (dupilumab) for injection in various countries, including UAE, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela, as well as Europe (such as UK, Hungary, Ireland, Latvia, Slovakia, Czech Republic, Belgium, Lithania, Greece, Spain, Maldova, Germany, Sweden, Italy, Bulgaria, Romania, Montenegro, Russia), and other countries like Zimbabwe, Australia, and New Zealand, Canada, Philippines, USA, South Africa, Thailand, China, Pakistan, Kazakhstan, Uzbekistan, Zambia, Kuwait, Sri Lanka, Singapore, Hong Kong, Afghanistan, Turkey, Malaysia, Qatar, Japan, Nepal, and many other countries. please reach out to us. We will provide you with the necessary information regarding the pricing and availability of DUPIXENT (dupilumab) for injection in the desired locations.
How to Get Access
If the Brand Name medication “DUPIXENT (dupilumab) for injection” is not approved or unavailable in your country, patients, physicians, and distributors/suppliers have the option to purchase and import it from Verve Biosciences. To begin the process, you can make an enquiry, and we will assist you in calculating the total cost to buy “DUPIXENT (dupilumab) for injection” online and arrange delivery to your location. To proceed, we will require a prescription from your treating doctor, and in certain countries, an import license may also be necessary. Throughout the process, our Patient Support team will provide guidance and support.
Verve Biosciences Pvt. Ltd.
Contact Person : Mr Rakesh Khanna
Email: info@cancermedicinesnetwork.com
Mobile: 91 9910645395
WhatsApp: +919910645395
FAQ's
How much does DUPIXENT cost?
The DUPIXENT price in India usually can vary depending on the wholesaler/pharmacy you visit. DUPIXENT is available as a brand name drug only, a generic version is not yet available.
What is the best price for dupilumab?
Please contact at urgent@cancermedicinesnetwork.com : (+91) 9910645395 for dupilumab price India. We take the guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Can I get DUPIXENT (dupilumab) for injection even if I am not based in India?
The Verve Biosciences helps patients in accessing or importing DUPIXENT (dupilumab), not approved in their home country against the legitimate prescription and in conformity with the all local laws and regulations of their home country.
